We also identified potential downstream regulatory genes, including PTGDS, GREM1, LAMA4, S100A14, PREX2, and GLS2. Therefore, our study offers new insights into the role and mechanism of SRPX2 in thyroid cancer and its potential as a biomarker for PTC prognosis. This evidence concerns the gene GREM1 and thyroid cancer.